Product Benefits

1. Superior Lipid Reduction (Dual Mechanism)

• Dual-Pathway Action: Combines Rosuvastatin (10mg), a potent statin that inhibits cholesterol production in the liver, with Ezetimibe (10mg), a cholesterol absorption inhibitor that blocks dietary and biliary cholesterol uptake in the small intestine. This synergistic effect leads to significantly lower LDL-C levels than either drug alone.

• Maximum Efficacy: This higher-strength combination is designed for patients who need more aggressive lipid lowering to reach their target LDL-C goals, especially those at high risk for cardiovascular events.

2. Cardiovascular Risk Management

• Reduced Risk of Major Events: By achieving optimal LDL-C reduction, it plays a critical role in preventing heart attacks, strokes, and the need for arterial revascularization procedures (e.g., angioplasty).

• Slows Atherosclerosis: Helps to slow the progression of atherosclerosis (hardening and narrowing of the arteries due to plaque buildup), improving long-term vascular health.

3. Comprehensive Cholesterol Profile Improvement

• Powerful LDL-C Lowering: Significantly reduces "bad" Low-Density Lipoprotein